Hao Long Selected Research

Nucleosome Assembly Protein 1

12/2021

NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Long Research Topics

Disease

50	Neoplasms (Cancer) 04/2024 - 01/2002
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 08/2002
15	Glioma (Gliomas) 01/2023 - 01/2012
12	Neoplasm Metastasis (Metastasis) 08/2021 - 03/2005
9	Carcinoma (Carcinomatosis) 05/2020 - 02/2004
7	Lung Neoplasms (Lung Cancer) 03/2023 - 03/2009
7	Esophageal Squamous Cell Carcinoma 05/2020 - 09/2008
7	Breast Neoplasms (Breast Cancer) 04/2013 - 05/2002
6	Adenocarcinoma of Lung 01/2021 - 12/2011
5	Carcinogenesis 12/2020 - 04/2006
5	Lymphatic Metastasis 07/2019 - 09/2015
4	Epilepsy (Aura) 02/2024 - 01/2018
4	Inflammation (Inflammations) 01/2023 - 01/2013
4	Hemorrhage 01/2017 - 06/2007
4	Esophageal Neoplasms (Esophageal Cancer) 05/2016 - 09/2008
3	Adenocarcinoma 01/2021 - 08/2002
3	Wounds and Injuries (Trauma) 01/2017 - 09/2007
2	Necrosis 04/2024 - 09/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 12/2011
2	Nasopharyngeal Carcinoma 08/2021 - 08/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2010
2	Spinal Cord Ischemia 11/2020 - 06/2013
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 05/2020 - 09/2019
2	Infections 03/2020 - 07/2013
2	Pain (Aches) 01/2020 - 12/2008
2	Hepatocellular Carcinoma (Hepatoma) 07/2011 - 12/2008
1	Drug Resistant Epilepsy 02/2024
1	Movement Disorders (Movement Disorder) 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Anastomotic Leak 01/2022
1	Starvation 12/2021
1	Neuroinflammatory Diseases 06/2021
1	Facial Nerve Diseases (Facial Nerve Disorders) 02/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2004
11	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2012
8	Messenger RNA (mRNA)IBA 10/2020 - 06/2005
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2014
6	CytokinesIBA 01/2023 - 09/2007
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2006
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
4	CateninsIBA 01/2019 - 11/2010
3	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2009
3	squamous cell carcinoma-related antigenIBA 05/2020 - 05/2004
3	EnzymesIBA 03/2014 - 05/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2009 - 10/2004
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	toripalimabIBA 01/2022 - 01/2021
2	VimentinIBA 03/2021 - 06/2017
2	Dihydrotachysterol (AT 10)IBA 02/2021 - 01/2021
2	Coloring Agents (Dyes)IBA 01/2021 - 05/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 10/2013
2	InterferonsIBA 01/2021 - 12/2014
2	diphenyl (biphenyl)IBA 12/2020 - 03/2014
2	BromidesIBA 12/2020 - 03/2014
2	Serum AlbuminIBA 05/2020 - 05/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2020 - 01/2018
2	Anaplastic Lymphoma KinaseIBA 01/2020 - 09/2015
2	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 11/2019 - 09/2015
2	C-Reactive ProteinIBA 09/2019 - 05/2016
2	Cadherins (E-Cadherin)IBA 12/2018 - 06/2017
2	Carcinoembryonic AntigenIBA 05/2016 - 05/2004
2	Indicators and Reagents (Reagents)IBA 05/2016 - 12/2011
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2015 - 03/2014
2	Casein Kinase II (Casein Kinase 2)IBA 07/2013 - 01/2012
2	ParaffinIBA 06/2010 - 03/2009
2	Imatinib Mesylate (Gleevec)FDA Link 04/2006 - 01/2006
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2006 - 01/2006
1	PhosphoenolpyruvateIBA 04/2024
1	InterleukinsIBA 04/2024
1	gamma-Aminobutyric Acid (GABA)IBA 02/2024
1	Volatile Fatty AcidsIBA 02/2024
1	apatinibIBA 12/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2023
1	mesoglycanIBA 10/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	hepatoma-derived growth factorIBA 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	Nucleosome Assembly Protein 1IBA 12/2021
1	Amino Acids FDA Link 12/2021
1	Mupirocin (Bactroban)FDA LinkGeneric 12/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2021

Therapy/Procedure

14	Therapeutics 02/2024 - 03/2005
9	Drug Therapy (Chemotherapy) 01/2022 - 05/2002
8	Lymph Node Excision (Lymph Node Dissection) 03/2023 - 11/2007
8	Immunotherapy 01/2023 - 06/2017
8	Esophagectomy 05/2021 - 09/2008
7	Radiotherapy 01/2021 - 12/2008
7	Thoracotomy 02/2018 - 01/2002
4	Adjuvant Chemotherapy 08/2021 - 03/2005
3	Segmental Mastectomy (Lumpectomy) 03/2023 - 07/2006
2	Length of Stay 01/2022 - 03/2011
2	Metastasectomy 08/2021 - 08/2021
2	Pneumonectomy (Lung Volume Reduction) 01/2021 - 08/2002
2	Aftercare (After-Treatment) 09/2018 - 12/2008
1	Immunomodulation 01/2023
1	Epidural Analgesia 10/2021
1	Analgesia 10/2021